You just read:

BioMarin Highlights New Results for Gene Therapy Valoctocogene Roxaparvovec at the 2017 American Society of Hemophilia (ASH) Meeting

News provided by

BioMarin Pharmaceutical Inc.

Dec 11, 2017, 09:00 EST